Skip to main content
ALNY logo
ALNY
(NASDAQ)
Alnylam Pharmaceuticals, Inc.
$303.05-- (--)
Loading... - Market loading

Alnylam Pharmaceuticals (ALNY) Stock Price & Financial Analysis

Alnylam Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$300.50 - $306.73
52-Week High$495.55
52-Week Low$283.10
Open$306.34
Volume986.82K
Average Volume (3M)1.06M
Market Cap41.97B
Shares Outstanding138.23M
P/E Ratio (TTM)72.71
Price to Sales (P/S)9.79
Price to Book (P/B)39.03
EV/EBITDA44.64
Revenue (TTM)4.29B
Net Income (TTM)577.22M
Free Cash Flow (TTM)643.34M
EPS (TTM)$4.26
Profit Margin13.46%
Operating Margin17.54%
Return on Equity (ROE)53.68%
Debt to Equity0.94
50-Day MA$307.22
200-Day MA$381.85
52-Week Change-1.61%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Alnylam Pharmaceuticals

What is the current stock price for ALNY?

As of the latest trading session, ALNY stock trades at $303.05. The 52-week range is $283.10–$495.55, with a day range of $300.50–$306.73.

What is the P/E ratio for ALNY?

Alnylam Pharmaceuticals's trailing P/E ratio is 72.7, meaning investors pay $72.7 for every $1 of annual earnings.

Does ALNY pay dividends?

Alnylam Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ALNY?

Based on 8 analysts, the consensus for ALNY is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ALNY?

Alnylam Pharmaceuticals's market capitalization is $41.89B, classifying it as a large-cap company..